Prosecution Insights
Last updated: April 19, 2026

AB Science

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18256721 MASITINIB FOR THE TREATMENT OF ALZHEIMER'S DISEASE CHONG, YONG SOO 1623 Final Rejection Jun 09, 2023
18034960 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INNER EAR DISORDERS THROUGH LOCAL ADMINISTRATION IN THE TYMPANIC AREA MOU, LIYUAN 1628 Non-Final OA May 02, 2023
17795076 MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT SUBPOPULATION SIMMONS, CHRIS E 1622 Final Rejection Jul 25, 2022
17779722 USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMA BAEK, BONG-SOOK 1611 Final Rejection May 25, 2022

Managing AB Science's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month